Registered entities
Amplyx Pharmaceuticals Inc
Reg. No. 20-4563467United States
Innovation
15 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 359 times.
| Year | Filings |
|---|---|
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
Investor mix
18 investors on record; lead investors include 3x5 Partners, Sofinnova Investments, RiverVest Venture Partners; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 61% |
| Private equity | 1 | 6% |
| Angel & family office | 3 | 17% |
| Other / undisclosed | 3 | 17% |